Verteporfin is a photosensitizing agent primarily used in photodynamic therapy for certain medical conditions, including age-related macular degeneration. In the context of hair loss, it has been studied for its potential to enhance hair regrowth by promoting vascularization and cellular activity in hair follicles when activated by light. Key distinguishing characteristics of verteporfin include its ability to selectively target abnormal cells and its mechanism of action that involves generating reactive oxygen species upon light activation, which may stimulate hair follicle activity.